Sector: Health Care.Industry: Biotechnology
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-04-27 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-03-19 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INBX | Inhibrx | -0.64% | 995.2M |
Inhibrx Company Questions & Answers
Q
How do I buy Inhibrx (INBX) stock?
A
You can purchase shares of Inhibrx (NASDAQ: INBX) through any online brokerage.
Q
Who are Inhibrx's (INBX) main competitors?
A
Other companies in Inhibrx’s space includes: Avidity Biosciences (NASDAQ:RNA), Trillium Therapeutics (NASDAQ:TRIL) and TCR2 Therapeutics (NASDAQ:TCRR).
Q
What is the target price for Inhibrx?
A
The latest price target for Inhibrx (NASDAQ: INBX) was reported by Jefferies on 2020-09-14. The analyst firm set a price target for 30.00 expecting INBX to rise to within 12 months (a possible 13.68% upside). 3 analyst firms have reported ratings in the last year.
Q
How much is Inhibrx (INBX) stock ?
A
The stock price for Inhibrx (NASDAQ: INBX) is $26.39 last updated Fri Mar 05 2021 21:00:01 GMT+0000 (Coordinated Universal Time).
Q
When is the next Inhibrx (INBX) dividend?
A
There are no upcoming dividends for Inhibrx.
Q
When is Inhibrx (NASDAQ:INBX) reporting earnings?
A
Inhibrx’s Q1 earnings are confirmed after-market from now on April 27, 2021.
Q
When is the upcoming split for INBX?
A
There is no upcoming split for Inhibrx.